Cargando…
Pan-Sigma Receptor Modulator RC-106 Induces Terminal Unfolded Protein Response In In Vitro Pancreatic Cancer Model
Pancreatic cancer (PC) remains one of the most lethal cancers worldwide. Sigma receptors (SRs) have been proposed as cancer therapeutic targets. Their main localization suggests they play a potential role in ER stress and in the triggering of the unfolded protein response (UPR). Here, we investigate...
Autores principales: | Cortesi, Michela, Zamagni, Alice, Pignatta, Sara, Zanoni, Michele, Arienti, Chiara, Rossi, Daniela, Collina, Simona, Tesei, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734580/ https://www.ncbi.nlm.nih.gov/pubmed/33260926 http://dx.doi.org/10.3390/ijms21239012 |
Ejemplares similares
-
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer
por: Tesei, Anna, et al.
Publicado: (2019) -
Sigma Receptors as Endoplasmic Reticulum Stress “Gatekeepers” and their Modulators as Emerging New Weapons in the Fight Against Cancer
por: Tesei, Anna, et al.
Publicado: (2018) -
Modeling neoplastic disease with spheroids and organoids
por: Zanoni, Michele, et al.
Publicado: (2020) -
Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate Cancer
por: Zamagni, Alice, et al.
Publicado: (2020) -
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents
por: Listro, Roberta, et al.
Publicado: (2020)